Shenzhen Weiguang Biological Products Co., Ltd.

¥20.05As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002880Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (5.46%)
Div yield 1.00%
ROE 7.00%
Biotechnology
Beta (5Y) 0.38
PE TTM 26.80
TSR TTM (26.22%)
Mkt cap ¥4.547B
ROIC 5.41%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥20
0.92%
(22.90%)
Hold 2|8|3|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.23
0.26
0.29
0.32
23.98%
30.19%
43.93%
45.12%
Revenue¥M
257.5
268.0
275.8
278.4
4.94%
5.14%
9.94%
13.16%
Peers (US$681.7M)
Cap (US$)
PE
666.5M
—
662.9M
18.20x
Capital
TTM
5Y
10Y
Leveragex
0.942
0.017
0.016
EBIT/Intx
1.870
0.792
0.831
Own earn%
(21.75)
(8.05)
(9.90)
Sh yield%
28.04
20.70
26.56
Owners
Insiders/Inst%
3.17
75.50
Short interest%
1.26
SBC / revenue%
4.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
25–30
$1 testx
−0.2
Incr. ROIC%
5